Maren Knödler

Leveraging Large Language Models for Decision Support in Personalized Oncology

Manuela Benary, Xing David Wang, Max Schmidt et al. · JAMA Network Open · 2023 · 282 citations · Full text

Medicine, Biomedical Informatics, Oncology +17

Expression of Amphiregulin and EGFRvIII Affect Outcome of Patients with Squamous Cell Carcinoma of the Head and Neck Receiving Cetuximab–Docetaxel Treatment

Ingeborg Tinhofer, Konrad Klinghammer, Wilko Weichert et al. · Clinical Cancer Research · 2011 · 94 citations · Full text

Medicine, Oncology, Pharmacology +17

VESTIGE: Adjuvant Immunotherapy in Patients With Resected Esophageal, Gastroesophageal Junction and Gastric Cancer Following Preoperative Chemotherapy With High Risk for Recurrence (N+ and/or R1): An Open Label Randomized Controlled Phase-2-Study

Elizabeth Smyth, Maren Knödler, Murielle Mauer et al. · Frontiers in Oncology · 2020 · 94 citations · Full text

Medicine, Oncology, Surgery +17

Randomised phase II trial to investigate catumaxomab (anti-EpCAM × anti-CD3) for treatment of peritoneal carcinomatosis in patients with gastric cancer

Maren Knödler, Justus Körfer, Volker Kunzmann et al. · British Journal of Cancer · 2018 · 85 citations · Full text

Medicine, Oncology, Pharmacology +14

Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy—final results of the larynx organ preservation trial DeLOS-II

Andreas Dietz, Gunnar Wichmann, Thomas Kuhnt et al. · Annals of Oncology · 2018 · 83 citations · Full text

Medicine, Oncology, Surgery +17